| John Perna, MD | |
|
777 Bannock St, Mc1914, Denver, CO 80204-4507 | |
| (303) 436-6000 | |
| (303) 436-6000 |
| Full Name | John Perna |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 777 Bannock St, Denver, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952442170 | NPI | - | NPPES |
| 01229038 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 22903 (Colorado) | Primary |
| Entity Name | Denver Health And Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477569838 PECOS PAC ID: 4688583578 Enrollment ID: O20031105000211 |
News Archive
In today's ageing population, resulting in a rising prevalence of chronic diseases such as neurodegeneration, the need for simple, non-invasive methods to diagnose or screen for important medical conditions becomes more and more relevant. Objective and cost-effective approaches capable of diagnosing early-stage disease in point-of-care clinical settings are necessary to facilitate the personalising of therapies to prevent or slow down pathology development.
Eli Lilly and Company and Merck, known as MSD outside the United States and Canada, today announced another immuno-oncology collaboration that will evaluate abemaciclib (LY2835219), Lilly's cyclin-dependent kinase (CDK) 4 and 6 inhibitor, and Merck's KEYTRUDA (pembrolizumab) in a Phase I study across multiple tumor types.
Working together with researchers in the Université Paris-Sud in France and University Medical Centre Göttingen in Germany, ICREA Research Professor Toni Gabaldón and his team at the Centre for Genomic Regulation in Barcelona read the genetic code of 33 separate strains of the yeast Candida glabrata, the second most common cause of candidiasis.
Galderma is proud to announce the launch of a new global initiative under the SKINPACT Programme that will provide support for two new projects in the field of community dermatology. The winning entries will be awarded funding to implement future projects to help shape advances in Community Leadership and Excellence in Education to improve communities and patient quality of life.
Researchers have added a new piece to the puzzle of how the brain selectively amplifies those distinctions that matter most from the continuous cascade of sights, sounds, and other sensory input.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Perna, MD 777 Bannock St, Mc1914, Denver, CO 80204-4507 Ph: () - | John Perna, MD 777 Bannock St, Mc1914, Denver, CO 80204-4507 Ph: (303) 436-6000 |
News Archive
In today's ageing population, resulting in a rising prevalence of chronic diseases such as neurodegeneration, the need for simple, non-invasive methods to diagnose or screen for important medical conditions becomes more and more relevant. Objective and cost-effective approaches capable of diagnosing early-stage disease in point-of-care clinical settings are necessary to facilitate the personalising of therapies to prevent or slow down pathology development.
Eli Lilly and Company and Merck, known as MSD outside the United States and Canada, today announced another immuno-oncology collaboration that will evaluate abemaciclib (LY2835219), Lilly's cyclin-dependent kinase (CDK) 4 and 6 inhibitor, and Merck's KEYTRUDA (pembrolizumab) in a Phase I study across multiple tumor types.
Working together with researchers in the Université Paris-Sud in France and University Medical Centre Göttingen in Germany, ICREA Research Professor Toni Gabaldón and his team at the Centre for Genomic Regulation in Barcelona read the genetic code of 33 separate strains of the yeast Candida glabrata, the second most common cause of candidiasis.
Galderma is proud to announce the launch of a new global initiative under the SKINPACT Programme that will provide support for two new projects in the field of community dermatology. The winning entries will be awarded funding to implement future projects to help shape advances in Community Leadership and Excellence in Education to improve communities and patient quality of life.
Researchers have added a new piece to the puzzle of how the brain selectively amplifies those distinctions that matter most from the continuous cascade of sights, sounds, and other sensory input.
› Verified 5 days ago
Oluyomi Obafemi, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 605 Bannock St # Mc2600, Denver, CO 80204 Phone: 303-602-3518 Fax: 303-602-3551 | |
Dr. Michael Steiner, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: 8181 E Tufts Ave Ste 560, Denver, CO 80237 Phone: 720-669-3470 Fax: 720-669-3480 | |
Dr. Christopher Ryan Lowe, PHARMD, BCPS, AE-C General Practice Medicare: Not Enrolled in Medicare Practice Location: 10400 E Alameda Ave, Denver, CO 80247 Phone: 303-360-1106 Fax: 303-360-1040 | |
Sheryl J Herner, PHARM.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1835 Franklin St Fl 5, Kaiser Hospital Medicine, Denver, CO 80218 Phone: 303-318-3656 | |
Mongthuong T Tran, PHARMD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1375 E 20th Ave, Denver, CO 80205 Phone: 303-764-5049 | |
Bharati Bhardwaja, General Practice Medicare: Not Enrolled in Medicare Practice Location: 1375 E 20th Ave, Skyline Medical Facility, Denver, CO 80205 Phone: 303-764-5351 | |
Teresita R Marcelo, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1055 Clermont St, Dept Of Veteran Affairs Medical Center, Denver, CO 80220 Phone: 303-399-8020 |